跳至主要内容
临床试验/NCT05193006
NCT05193006Unknown不适用

Assessment of Histologic Prognostic Factors in Peritoneal Malignant Mesothelioma

Hospices Civils de Lyon6 个研究点 分布在 6 个国家目标入组 300 人开始时间: 2021年12月28日最近更新:
适应症

试验速览

阶段
不适用
入组人数
300
试验地点
6
主要终点
Assessment of pronostic impact of nuclear grade in comparison with combined grade in peritoneal malignant mesothelioma

研究概览

简要总结

Malignant peritoneal mesothelioma is a rare neoplasm. The most common type, the epithelioid type, has been further divided into histological patterns of tubulo-papillary, acinar, adenomatoid, micropapillary, or solid. Its prognosis is improved by the use of a locoregional treatment combining extensive cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC), which increases survival up to 50 months. Histology is one of the most important prognostic variable that, forms the basis for treatment decisions. However, the prognostic of the epithelioid type varies greatly due to its tumor heterogeneity. It is therefore necessary to find prognostic factors of malignant epithelioid peritoneal mesothelioma in order to better define the therapeutic strategy. Among histological factors, solid growth, tumor necrosis, nuclear atypia, and mitotic count were found to be independent prognostic factors in epithelioid malignant pleural mesothelioma. However, in epithelioid malignant peritoneal mesothelioma (EMPM), these factors were studied in small and heterogeneous series in terms of histological growth and definitions used for histological factors. The present large study was conducted to investigate the prognostic impact of several histologic factors in EMPM. Their prognosis impacts were assessed using overall survival (OS) and progression-free survival (PFS) in EMPM.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • - peritoneal malignant mesothelioma

排除标准

  • opposition to reuse personnal data

结局指标

主要结局

Assessment of pronostic impact of nuclear grade in comparison with combined grade in peritoneal malignant mesothelioma

时间窗: 3 months to 4 years

Assessment by the review of pathologists

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (6)

Loading locations...

相似试验